Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 58, No. 1, 2012
Issue release date: December 2011
Section title: Behavioural Science Section / Mini-Review
Free Access
Gerontology 2012;58:70–78

Aging in Autism Spectrum Disorders: A Mini-Review

Happé F.a · Charlton R.A.b, c
aMRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, and bClinical Neuroscience, St George’s, University of London, London, UK; cDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Ill., USA
email Corresponding Author

Prof. Francesca Happé

MRC Social, Genetic and Developmental Psychiatry Centre

Institute of Psychiatry (PO 80), King’s College London

De Crespigny Park, Denmark Hill, London SE5 8AF (UK)

Tel. +44 207 848 0873, E-Mail francesca.happe@kcl.ac.uk

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


This article addresses an important and barely researched topic: what happens to children with autism spectrum disorders when they grow old. We review the small published literature on aging in autism. We then consider the relevance of research on ‘neurotypical’ aging in core domains of autistic impairment: social cognition, executive function, cognitive style and memory. Research themes from the study of normal aging, including cognitive reserve, compensation, quality of life, loneliness and physical health are of relevance for future research on autism. Studies of aging in autism will be important not only to plan appropriate services, but also to shed light on the full developmental trajectory of this neurodevelopmental condition, and perhaps provide clues to neuropathology and etiology.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Behavioural Science Section / Mini-Review

Received: October 29, 2010
Accepted: May 25, 2011
Published online: August 24, 2011
Issue release date: December 2011

Number of Print Pages: 9
Number of Figures: 0
Number of Tables: 0

ISSN: 0304-324X (Print)
eISSN: 1423-0003 (Online)

For additional information: http://www.karger.com/GER

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.